Hormone Refractory Prostate Cancer

Links shared publicly online about this topic

Cabazitaxel Increased Survival For Patients With Advanced Hormone-Refractory Prostate Cancer

medicalnewstoday.com — “Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improveView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 4, 2010 at 6:08 pm By:

mnt_pharma MNT Pharma News Health News and Pharma

Cabazitaxel Increased Survival For Patients With Advanced Hormone-Refractory Prostate Cancer http://mnt.to/3yt5 #pharma #pharmaceutical

2 years ago...

Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of Taxotere

professional.cancerconsultants.com — “Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of TaxotereView full resource at professional.cancerconsultants.com

  • View Related
  • Share

Most Recently Shared on March 5, 2010 at 3:38 pm By:

prostatecancer_ Prostate Cancer Support

Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of ... http://bit.ly/asi3l0

2 years ago...

A potential new target for treatment of hormone refractory prostate cancer

physorg.com — “A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer. The research, published by Cell Press in the April 7th issue of the journal Cancer Cell, may also drive creation of new strategies ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on April 6, 2009 at 8:03 pm By:

FightCancer FightCancer Health News

A potential new target for treatment of hormone refractory prostate cancer http://tinyurl.com/ckakb8

3 years ago...

EMEA Gives Official Scientific Advice On Clinical Phase IIb Efficacy Study Of Inecalcitol In Hormone-refractory Prostate Cancer

medicalnewstoday.com — “Hybrigenics, a bio-pharmaceutical company with a focus on research and development of new cancer treatments and specialized in protein interactions, announced that it has received the official sciView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 4, 2010 at 3:10 pm By:

mnt_clinical MNT Clinical Trials Health News

EMEA Gives Official Scientific Advice On Clinical Phase IIb Efficacy Study Of Inecalcitol In Hormone-refractory Prosta... http://mnt.to/3xbN

2 years ago...

Second-Line Treatment for Metastatic Hormone Refractory Prostate Cancer - Renal and Urology News

renalandurologynews.com — “For the first time, it appears there is a second-line treatment option for men with metastatic hormone refractory prostate cancer.View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on December 30, 2010 at 6:18 pm By:

renalandurology Renal Urology News Urology, Medical Publisher, Health News, and Nephrology

Second-Line Treatment for Metastatic Hormone Refractory Prostate Cancer: For the first time, it appears there is... http://bit.ly/eQ5bgH

1 year ago...

Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refractory Prostate Cancer | Yacht Vacations & Charters

yachtchartersmagazine.com — “Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refractory Prostate Cancer | Yacht Vacations & ChartersView full resource at yachtchartersmagazine.com

  • View Related
  • Share

Most Recently Shared on March 3, 2010 at 11:51 pm By:

prostatecancer_ Prostate Cancer Support

Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refractory ... http://bit.ly/9XVJ4d

2 years ago...

Phase 3 trial: Cabazitaxel improves survival in patients with metastatic hormone-refractory prostate cancer

news-medical.net — “Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 4, 2010 at 4:28 am By:

NewsMedical News-Medical.Net Health News

Phase 3 trial: Cabazitaxel improves survival in patients with metastatic hormone-refractory prostate cancer: Sanof... http://bit.ly/aFfmua

2 years ago...

UroToday - Docetaxel in combination with prednisolone for hormone refractory prostate cancer - Abstract

urotoday.com — “Breaking urology news written by urologists for urologists. global leaders in urology provide key conference report coverage and daily articles on top urology headlines.View full resource at urotoday.com

  • View Related
  • Share

Most Recently Shared on November 13, 2009 at 8:34 am By:

prostatecancer_ Prostate Cancer Support

Docetaxel in combination with prednisolone for hormone refractory prostate ... http://bit.ly/1KtdM

3 years ago...

Medical News: FDA Okays First Drug for Hormone-Refractory Prostate Cancer - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved the chemotherapy agent cabazitaxel (Jevtana) to be used in conjunction with the steroid prednisone for treatment of hormone-refractory prostate cancer.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on June 17, 2010 at 10:54 pm By:

FightCancer FightCancer Health News

FDA Okays First Drug for Hormone-Refractory Prostate Cancer http://bit.ly/aKJd8d

2 years ago...

Prostate Cancer Hormone Therapy

webmd.com — “Men with locally advanced prostate cancer treated with radiation need 3 years -- not 6 months -- of difficult hormone therapy, a clinical trial shows.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on June 12, 2009 at 9:11 pm By:

Urology Article | Prostate Cancer

mdlinx.com — “Combination Therapy with VP16 and Ethinylestradiol for Hormone-Refractory Prostate Cancer: Good Response with TolerabilityView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 2, 2010 at 9:07 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Combination Therapy with VP16 and Ethinylestradiol for Hormone-Refractory Prostate Cancer: Good Response w... http://bit.ly/cfwm5v #urology

2 years ago...

Hormonal and Radiation Therapy in Prostate Cancer

onclive.com — “Hormonal and Radiation Therapy in Prostate CancerView full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on April 5, 2011 at 4:48 pm By:

ONClive Editor Oncology

Dr. Sandler from Cedars-Sinai Medical Center on the Combination of Hormonal and Radiation Therapy in Prostate Cancer http://goo.gl/Lx0C9

1 year ago...

Hormones and prostate cancer - Saga

saga.co.uk — “Prostate cancer growth is not always driven by testosterone, which is why hormone treatment sometimes fails. Siski Green reportsView full resource at saga.co.uk

  • View Related
  • Share

Most Recently Shared on August 1, 2011 at 11:02 am By:

prostatediaries john clay mchugh Surgeon, Urologist, Physician, and Doctor

Hormones and prostate cancer (Saga): Prostate cancer growth is not always driven by testosterone, which is why h... http://bit.ly/noDhnt

10 months ago...

Progenics presents Phase 1 PSMA ADC therapy study data for taxane-refractory prostate cancer at ASCO 2010

news-medical.net — “Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane cView full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 8, 2010 at 6:29 pm By:

Genetics_News News-Medical.Net Health News

Genetics News: Progenics presents Phase 1 PSMA ADC therapy study data for taxane-refractory prostate cancer at A... http://buzzup.com/zr0u

2 years ago...

Hormonal therapy of prostate cancer - Abstract

urotoday.com — “Hormonal therapy of prostate cancer - AbstractView full resource at urotoday.com

  • View Related
  • Share

Most Recently Shared on June 29, 2010 at 8:42 am By:

prostatecancer_ Prostate Cancer Support

Hormonal therapy of prostate cancer - Abstract http://bit.ly/dp83o3

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • mnt_pharma

    MNT Pharma News

    The latest pharma industry news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • prostatecancer_

    Prostate Cancer

    You just hit the official Twitter Page of Prostate Cancer Community! We have the info you need when it come to Prostate Cancer. Dive in and get connected!

    View Profile

  • FightCancer

    FightCancer

    Cancer news feed, formerly part of a blog. RSS suggestions welcome.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390